Bank of America downgraded Sun Pharma stock to ‘underperform’ from ‘neutral’, citing risks to premium valuations and slower speciality execution. The brokerage cut its target price, flagging concerns over Ilumya’s Medicare exposure, pricing pressures, and limited earnings visibility despite strong initial performance.
Mixed geopolitical signals making market moves hard to decode: Seth R Freeman
Global equity markets, led by the US, have recovered strongly, reaching new highs despite ongoing geopolitical tensions. However, volatile oil prices, influenced by conflicting US-Iran
April 20, 2026